Watchlist Price Alert

Arcosa Inc. (ACA)

NYSE: ACA · Real-Time Price · USD

86.95

0.14 (0.16%)

At close: May 09, 2025, 3:59 PM

87.00

0.06%

After-hours: May 09, 2025, 04:05 PM EDT

0.16% (1D)

Bid	79.58
Market Cap	4.24B
Revenue (ttm)	2.57B
Net Income (ttm)	93.7M
EPS (ttm)	1.59
PE Ratio (ttm)	54.69
Forward PE	18.62
Analyst	Buy

Ask	90
Volume	179,339
Avg. Volume (20D)	336,270
Open	86.97
Previous Close	86.81
Day's Range	85.94 - 87.24
52-Week Range	68.11 - 113.43
Beta	1.00

About ACA

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol ACA

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ACA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Arcosa has released their quartely earnings on May 6, 2025:

Revenue of $632M exceeds estimates by $17.5M, with 5.58% YoY growth.

EPS of 0.49 exceeds estimates by 0.31, with -32.88% YoY decline.

Why Price Moved

1 month ago

-3.7%

Shares of companies within the broader industrial ... Unlock content with Pro Subscription

1 month ago

+10.67%

Shares of machinery, electrical equipment and engineering companies are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

News

5 days ago · seekingalpha.com

Arcosa, Inc. (ACA) Q1 2025 Earnings Call Transcript

Arcosa, Inc. (NYSE:ACA ) Q1 2025 Earnings Conference Call May 7, 2025 8:30 AM ET Company Participants Erin Drabek - Director of Investor Relations Antonio Carrillo - President and Chief Executive Offi...

6 days ago · zacks.com

Arcosa (ACA) Q1 Earnings and Revenues Beat Estimates

Arcosa (ACA) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.73 per share a year ago.

6 days ago · businesswire.com

Arcosa, Inc. Announces First Quarter 2025 Results

DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa,” the “Company,” “We,” or “Our”), a provider of infrastructure-related products and solutions, today announced results for the first quarter ...

1 week ago · zacks.com

New Strong Sell Stocks for May 2nd

ARCB, ACA and BAND have been added to the Zacks Rank #5 (Strong Sell) List on May 2, 2025.

1 week ago · wsj.com

CVS Beats Wall Street Expectations, Plans to Withdraw From ACA Business

The healthcare company also struck a deal with Novo Nordisk to sell Wegovy at a reduced price for cash-paying customers through its pharmacies.

2 weeks ago · businesswire.com

Arcosa, Inc. Announces Timing of First Quarter 2025 Earnings Release and Conference Call

DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa” or the “Company”), a provider of infrastructure-related products and solutions, today announced that it will release results for the first q...

3 weeks ago · zacks.com

New Strong Sell Stocks for April 15th

AAL, ACA and BLKB have been added to the Zacks Rank #5 (Strong Sell) List on April 15, 2025.

1 month ago · zacks.com

Is the Options Market Predicting a Spike in Arcosa (ACA) Stock?

Investors need to pay close attention to Arcosa (ACA) stock based on the movements in the options market lately.

1 month ago · zacks.com

New Strong Sell Stocks for April 7th

ASTS, AMPY and ACA have been added to the Zacks Rank #5 (Strong Sell) List on April 7, 2025.

1 month ago · seekingalpha.com

Arcosa Is Poised For A Rebound In 2025 (Rating Upgrade)

ACA's topline grew 14.4% YoY in Q4 2024, driven by strong pricing and recent acquisitions, despite a 14% decline in Transportation Products revenue. Expect continued growth in 2025, fueled by strong i...

Load More News